Who is sponsoring NCT05464953?

NCT05464953 is sponsored by Al-Azhar University.

What drugs are being tested in NCT05464953?

Interventions in NCT05464953: Triamcinolone Acetonide, Formulated Triamcinolone.

What condition does NCT05464953 study?

NCT05464953 studies Diabetic Macular Edema of Left Eye.

Is NCT05464953 still recruiting?

NCT05464953 is currently completed. Last updated 19 July 2022.

Last reviewed 2022-07-19 · How we verify

NCT05464953

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Suprachoroidal Triamcinolone Versus Posterior Subtenon Triamcinolone Alone or Formulated in the Management of Diabetic Macular Edema.

Completed NA Last updated 19 July 2022

What this trial tests

NA trial testing Triamcinolone Acetonide in Diabetic Macular Edema of Left Eye in 75 participants. Completed in 30 April 2022.

Timeline

20 January 2020

Primary endpoint
20 April 2022

30 April 2022

Quick facts

Lead sponsor	Al-Azhar University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	75
Start date	20 January 2020
Primary completion	20 April 2022
Estimated completion	30 April 2022
Sites	1 location across Egypt

Drugs / interventions tested

Triamcinolone Acetonide — full drug profile →
Formulated Triamcinolone — full drug profile →

Conditions studied

Diabetic Macular Edema of Left Eye — all drugs for Diabetic Macular Edema of Left Eye →

Sponsor

Al-Azhar University

Who can join

Adults 40 to 69, any sex, with Diabetic Macular Edema of Left Eye. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background Retinal vascular disorders, such as diabetic retinopathy, hypertensive retinopathy, retinal hemorrhage, and retinal vein occlusion are significant causes of vision impairment and blindness worldwide. Diabetic retinopathy (DR) is the most common retinal vascular disorder and is the leading cause of vision loss among patients aged 25 to 74 years. Aim to compare formulated Posterior Subtenon Triamcinolone acetonide (PSTA) injection versus Posterior Subtenon Triamcinolone acetonide alone versus suprachoroidal triamcinolone in the management of diabetic macular edema.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Suprachoroidal triamcinolone versus posterior subtenon triamcinolone either alone or formulated in the management of diabetic macular edema.
Tharwat E, Ahmed REH, Eltantawy B, Ezzeldin ER, et al · · 2023 · cited 2× · PMID 37698662 · DOI 10.1007/s10792-023-02856-2
Suprachoroidal triamcinolone versus Posterior subtenon triamcinolone either alone or formulated in the management of diabetic macular edema.
Tharwat E, Ahmed REH, Eltantawy B, Ezzeldin ER, et al · · 2022 · DOI 10.21203/rs.3.rs-1909132/v1

Verify or expand the search:

Other trials of Triamcinolone Acetonide

Trials testing the same drug.

NCT07453238 — Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata · Phase 4 · not yet recruiting
NCT07100145 — Efficacy of Coconut Gel Compared to Corticosteroid Gel in the Management of Oral Lichen Planus · Phase 4 · not yet recruiting
NCT06401317 — Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA) · Phase 2 · recruiting
NCT06977568 — A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjec · Phase 2 · terminated
NCT07420166 — Comparison of Intralesional Triamcinolone Acetonide Treatment With Intralesional Verapamil Hydrochloride in Keloids · NA · completed

Other Al-Azhar University trials

Trials by the same sponsor.

NCT06489327 — Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery · NA · recruiting
NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
NCT07500194 — Quad Helix vs RME for Posterior Cross-bite in Egyptian Children · NA · not yet recruiting
NCT07360756 — Ultrasonographic ONSD as a Predictor of PDPH in Spinal Anesthesia for Cesarean Delivery · not yet recruiting
NCT07343570 — Comparison of Quadratus Lumborum and Combined Groin Nerve Blocks for Postoperative Analgesia After Open Inguinal Hernia · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05464953 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al-Azhar University
Last refreshed: 19 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05464953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing